Clinical Trial: Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681713) titled 'Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)' on June 26.

Brief Summary: The purpose of this study is to confirm the treatment effects of vatiquinone on the key measures of FA disease progression.

Study Start Date: Aug. 15

Study Type: INTERVENTIONAL

Condition: Friedreich's Ataxia

Intervention: DRUG: Vatiquinone

Vatiquinone will be administered per dose and schedule specified in the arm.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: PTC Therapeutics

Disclaimer: Curated by HT Syndication....